Clinical Activity and Molecular Correlates of Response to Atezolizumab ± Bevacizumab vs Sunitinib in RCC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Clinical Activity and Molecular Correlates of Response to Atezolizumab Alone or in Combination With Bevacizumab Versus Sunitinib in Renal Cell Carcinoma
Nat. Med. 2018 Jun 01;24(6)749-757, DF McDermott, MA Huseni, MB Atkins, RJ Motzer, BI Rini, B Escudier, L Fong, RW Joseph, SK Pal, JA Reeves, M Sznol, J Hainsworth, WK Rathmell, WM Stadler, T Hutson, ME Gore, A Ravaud, S Bracarda, C Suárez, R Danielli, V Gruenwald, TK Choueiri, D Nickles, S Jhunjhunwala, E Piault-Louis, A Thobhani, J Qiu, DS Chen, PS Hegde, C Schiff, GD Fine, T PowlesFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.